RoC Skincare: The Retinol Cleanser That Cannot Do What It Says

EvilCorporations.com • Case No. 5:25-cv-01755, N.D. Cal. • 37 min read

The Non-Financial Ledger: What This Really Cost

Think about the specific person who buys this product. She is probably standing in a CVS or a Target skincare aisle, scanning labels. She has noticed something in the mirror that bothers her. Maybe it is a line at the corner of her mouth she did not used to have. Maybe it is the texture of her skin after years of sun. She is not buying a luxury item; she is buying hope, at $10 to $15 a bottle, from a brand calling itself America’s number one most awarded retinol. She does not have a biochemistry degree. She should not need one. She reads the label, it says “ADVANCED RETINOL,” it says 97% of women saw reduced deep wrinkles, it has a dermatologist quote on the website telling her she gets “the benefits of retinol in the convenience of a cleanser.” She buys it. She uses it every morning and every night for weeks, 30 seconds of massaging it in, rinsing it off, patting dry, exactly as the directions say.

Nothing happens. Nothing was ever going to happen. The lawsuit alleges the product physically cannot deliver on its promises because of how it is designed: rinse it off and you wash the retinol away before it can do a single thing. That is not a disclaimer in the fine print. That is the entire product design. The whole mechanism of a face wash, the thing that makes it a cleanser, is the thing that the lawsuit says makes the retinol useless.

What she loses is small enough individually that she probably will not sue on her own. Fifteen dollars. Maybe $45 if she buys it three times like plaintiff Tina Marie Barrales did between September and December 2024. But she also loses the time. The months of believing she was doing something good for her skin, building a routine, trusting a label. She loses the quiet dignity of making an informed choice. She was not given the information she needed to make one.

The lawsuit describes five named plaintiffs. Ivy Karina Vales bought it at a Target in San Jose. Tina Marie Barrales bought it three times at CVS and Target in Huntington Park. Cindy Doerr bought it at a Walmart in Lawrenceville, Illinois. Adelina Pepenella bought it at a Duane Reade or CVS in New York City. Kimberly Caudle bought it at an Ulta in St. Louis. Five women in five cities who read the same label and were told the same thing and paid for something that the company, according to the complaint, knew could not work as advertised. Behind each of them is everyone else who ever picked up that purple bottle and believed the number on the back: 97%.

The deeper insult is that real retinol skincare products exist. Dermatologist-prescribed tretinoin works. Properly formulated leave-on retinol serums work, if you apply them correctly, consistently, for months. The science of retinol is real. What RoC allegedly did was borrow the credibility of that science, put the word on the bottle, and attach it to a product whose own directions for use guarantee the active ingredient never gets a chance to function. The people hurt by this are the ones who trusted a brand with decades of name recognition and a marketing budget large enough to call itself America’s most awarded.

Legal Receipts: What the Documents Actually Say

The following are verbatim excerpts from the class action complaint filed February 19, 2025, in the United States District Court for the Northern District of California, Case No. 5:25-cv-01755. These are direct quotes from the filed legal document, reproduced here because the specific language matters.

“RoC exploits consumers’ perception of the benefits of retinol and consumers’ lack of knowledge about how retinol works by deceptively advertising and selling a rinse-off ‘Retinol Correxion Deep Wrinkle Serum Cleanser’ that purports to deliver the commonly understood dermatologic benefits of retinol—but is rinsed off right away, therefore minimizing its contact time with the target organ, in this case the skin.” Class Action Complaint, Paragraph 2 — Case No. 5:25-cv-01755, N.D. Cal. (Feb. 19, 2025)

• This paragraph directly alleges that RoC’s business model depends on exploiting a knowledge gap: consumers know retinol has benefits, but most do not know the biological process required to achieve them. The complaint calls this exploitation, not oversight.
• The phrase “minimizing its contact time with the target organ” is legal and scientific language for something simple: washing your face removes the product from your face before it can do anything.
• This is the core fraud allegation. Every other claim in the lawsuit flows from this one fact.

“Retinol is a relatively unstable chemical. It must be properly packaged, shipped, and stored, otherwise it loses its efficacy. RoC does not properly package, ship or store the subject retinol product. As a result, by the time a consumer purchases the subject products, the retinol is no longer active.” Class Action Complaint, Paragraph 2 — Case No. 5:25-cv-01755, N.D. Cal. (Feb. 19, 2025)

• The complaint identifies a second, separate reason the product allegedly fails: even before the rinse problem, the retinol ingredient itself may be chemically degraded by the time the bottle reaches a consumer’s bathroom.
• Retinol requires aluminum packaging and temperatures below 68°F to remain stable. RoC uses plastic containers and sells through retail stores with no temperature controls.
• This means the complaint alleges two compounding failures: a formulation-and-delivery failure (rinse-off) and a supply-chain failure (degraded ingredient). Either one alone would allegedly make the product ineffective; together, they make the advertised benefits scientifically impossible.

“Even prescription tretinoin (synthetic active retinoic acid), which bypasses the complex conversion process of retinyl esters → retinol → retinaldehyde → retinoic acid, comes with specific application guidelines. Users are advised to ‘avoid washing the skin treated with tretinoin for at least 1 hour after applying it.'” Class Action Complaint, Paragraph 25, citing FDA label for RENOVA® (tretinoin cream 0.05%)

• This is the most damaging scientific point in the entire complaint. The FDA-approved prescription-strength version of the active form of retinol, which skips all the enzymatic conversion steps that regular retinol requires, still needs at least one full hour of skin contact to work.
• RoC’s product directions say to apply it and rinse it off after 30 seconds. If the most potent, prescription-only, already-active form of the compound needs 60 minutes minimum, a rinse-off consumer cleanser containing a far weaker precursor form gets zero fraction of the required contact time.
• This is the complaint using the FDA’s own label to demonstrate that RoC’s product directions are incompatible with the claimed benefits.

“Experience RoC’s award-winning retinol products, which manage to deliver the good effects of retinol (exfoliation, collagen stimulation, and even radiant skin tone) while skipping the bad ones (dryness, irritation). That combination is especially true in their Retinol Correxion Deep Wrinkle Serum Cleanser. With this product, you get the benefits of retinol in the convenience of a cleanser.” Dermatologist-attributed paragraph on RoC’s product webpage, quoted in Class Action Complaint, Paragraph 33

• The complaint includes this quote to show that RoC used a third-party authority figure, a dermatologist, to make the core efficacy claim directly to consumers on its own website.
• The claim of “collagen stimulation” from a rinse-off product is directly challenged by the complaint’s scientific argument: collagen synthesis requires retinol to reach living keratinocytes in the deeper epidermis, which requires hours of skin contact and enzymatic conversion. A 30-second wash cannot achieve this.
• The complaint does not allege this dermatologist lied. It alleges RoC published this statement as part of a marketing campaign that, taken as a whole, was likely to deceive a reasonable consumer.

“Defendant’s conduct was fraudulent, malicious, and in reckless disregard of the truth such that an award of punitive damages is appropriate.” Class Action Complaint, Paragraph 52 — Count I, Multistate Consumer Protection Class

• Punitive damages are reserved for conduct the court finds was done with knowing disregard for the truth. This is the plaintiffs’ attorneys arguing that this was not a mistake or an oversight, but a deliberate choice to market a product with claims the company knew or should have known were false.
• This language appears in the multistate consumer protection count, meaning it applies to buyers across all 14 named states simultaneously.

Societal Impact: Who Gets Hurt When Beauty Brands Lie

Public Health

This lawsuit sits at the intersection of cosmetics marketing and public science literacy. The harms are real, documented in the complaint, and extend beyond the individual plaintiffs.

• Consumers who believe they are treating aging skin with retinol may delay or forgo consulting a dermatologist for clinically effective options, including FDA-approved prescription tretinoin, because they think their OTC routine is already working. This complaint directly documents that misbelief as its core injury.
• The complaint describes retinol as a chemical that requires a specific biological cascade: retinyl esters convert to retinol, then to retinaldehyde, then to retinoic acid, which must then bind to RAR and RXR nuclear receptors in living keratinocytes. A consumer buying this product has no reasonable way to know any of this, and the packaging exploits exactly that knowledge gap to make a sale.
• The “retinoid reaction” associated with real, effective retinol use (dryness, peeling, redness) is actually an indicator that the compound is working biologically. The RoC product advertises delivering retinol benefits “while skipping the bad ones” like dryness. The complaint implies users may interpret the absence of these side effects as a sign the product is a gentler form of retinol, when it may instead signal that no active biological process is occurring at all.
• OTC retinol products are sold as cosmeceuticals, a category that sits outside FDA drug regulation. The complaint notes that retinol is twenty times less potent than prescription tretinoin and requires enzymatic conversion to function. This case illustrates a structural gap: a product can market itself using the language of clinically validated science while operating in a regulatory zone that requires no proof of efficacy before sale.

Economic Inequality

The price point of this product, and where it was sold, tells you exactly who was targeted and who paid.

• The named plaintiffs paid between $10 and $15 per bottle at Target, CVS, Walmart, Ulta, and Duane Reade. These are mass-market retailers, not prestige counters at Sephora or Nordstrom. This product was positioned specifically to reach price-sensitive consumers who want effective skincare but cannot spend $50 to $200 on premium serums.
• The complaint states that “the price of the Retinol Rinse-Off Cleanser is higher because it is marketed as providing the benefits of retinol.” This means RoC charged a premium above what a basic cleanser would cost, and that premium was allegedly built entirely on claims that cannot be fulfilled. Consumers paid extra for nothing.
• One named plaintiff, Tina Marie Barrales, bought the product three times between September and December 2024, spending approximately $45 total. That spending pattern suggests she believed the product was working or needed more time to work, consistent with the complaint’s argument that consumers lack the scientific knowledge to identify the deception themselves.
• The lawsuit pursues a class covering all U.S. buyers, with specific subclasses in 14 states. The aggregate amount in controversy exceeds $5,000,000, exclusive of interest, fees, and costs. At $10 to $15 per unit, that represents hundreds of thousands of individual purchases, each representing a person who reached for a drugstore shelf and trusted a label.
• Individual litigation is economically impossible at this price point. The complaint explicitly acknowledges this: “Individual litigation is not economically feasible given the complex and relatively costly litigation necessary to establish Defendant’s liability.” The class action mechanism is the only legal tool that makes accountability possible for a $10 purchase, and it is being deployed here precisely because RoC’s alleged strategy only works at scale, in small amounts, across a very large number of transactions.

The “Cost of a Life” Metric

The lawsuit alleges damages exceeding $5,000,000 across the nationwide class. At the product’s price point, this translates into a specific scale of exploitation worth visualizing.

The Timeline: From Purchase to Federal Court

Five consumers in four states noticed the same thing: a product with a bold retinol claim that did not deliver. Here is how the documented sequence of events unfolded.

What Now: Who Runs This and What You Can Do

RoC Opco LLC is a Delaware limited liability company with its principal place of business in New York, New York. It is owned by two Delaware corporations also headquartered in New York. The complaint does not name individual executives, so specific officers are not listed here.

The Corporate Structure

• Defendant: RoC Opco LLC. Delaware limited liability company. Principal place of business: New York, NY. Manufactures, advertises, markets, distributes, and sells the Retinol Rinse-Off Cleanser.
• Parent companies: Two Delaware-incorporated corporations with principal places of business in New York. Names are listed as [REDACTED – Not in Source]. RoC is a citizen of New York and Delaware by virtue of its members.
• The product is sold through Target, CVS, Walmart, Walgreens, Ulta Beauty, Duane Reade, and RoC’s own website. Every one of those retail channels is a pipeline for the allegedly deceptive product to reach consumers nationwide.

Regulatory Watchlist

• Federal Trade Commission (FTC): The FTC has authority over deceptive advertising claims for cosmetics and personal care products. The “97% of women saw reduced deep wrinkles” marketing claim is exactly the type of unsubstantiated performance claim the FTC has pursued in enforcement actions. File a complaint at ftc.gov/complaint.
• Food and Drug Administration (FDA): The FDA regulates cosmetics under the Federal Food, Drug, and Cosmetic Act and has specific authority over labeling claims. When a cosmetic claims to alter the structure or function of the skin, it may cross the line into drug territory, requiring FDA approval. The complaint’s reference to collagen stimulation is directly relevant. Report concerns at fda.gov/safety/report-problem-fda.
• California Attorney General (AG): California’s Unfair Competition Law and Consumer Legal Remedies Act, both cited in this complaint, can be enforced by the AG on behalf of all California consumers. The AG’s office accepts consumer fraud complaints at oag.ca.gov.
• New York Attorney General (AG): New York Gen. Bus. Law §§ 349 and 350 are specifically invoked in this complaint. The NY AG enforces both and accepts consumer fraud complaints at ag.ny.gov.
• Illinois and Missouri State AGs: Both the Illinois Consumer Fraud and Deceptive Business Practices Act (815 ILCS 505/2) and the Missouri Merchandising Practices Act (§ 407.010) are cited. Consumers in those states can file complaints with their respective AG offices.

What You Can Do Right Now

• If you bought RoC’s Retinol Rinse-Off Cleanser at any point, visit ClassAction.org to look up Case No. 5:25-cv-01755 and connect with the litigation. Keeping your receipt or any purchase record strengthens the class.
• Talk to the people around you about ingredient science before buying. Retinol is a real compound with real, documented benefits, but only when used in leave-on formulations, applied consistently, at the right concentrations, in the right packaging. The word “retinol” on a label is not the same as retinol that works.
• Support organizations that advocate for stronger FTC and FDA enforcement of cosmetics advertising claims. The structural problem here is a regulatory gap: a cosmeceutical can make drug-adjacent claims with no pre-market efficacy proof. That gap is how this product allegedly got to market and onto drugstore shelves.
• If you are a dermatologist, esthetician, pharmacist, or anyone who works in skincare, the technical science in this complaint is worth sharing with clients. The rinse-off retinol problem applies to any face wash or body wash that claims retinol benefits; this is a category-wide issue.
• Write to RoC directly and demand corrective advertising and a refund: RoC Opco LLC, New York, NY. Public corporate accountability pressure, before and during litigation, has a documented history of accelerating settlements in consumer class actions.